Navigation Links
Boston Scientific's TAXUS® Element™ Stent Demonstrates Strong Outcomes in Diabetic Patients
Date:9/22/2010

NATICK, Mass., Sept. 22 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced results from an analysis of 1,166 patients from its PERSEUS clinical program comparing the performance of the TAXUS® Element™ Paclitaxel-Eluting Coronary Stent System in diabetic versus non-diabetic patients.  Results demonstrated that despite the known increased risk of restenosis for diabetics versus non-diabetics in patients undergoing coronary revascularization, the TAXUS Element Stent had comparable levels of target lesion revascularization (TLR) and late loss in both diabetic and non-diabetic patients.  Analysis of the data was presented by Louis A. Cannon, M.D., of the Cardiac and Vascular Research Center of Northern Michigan in Petoskey, Michigan, and Co-Principal Investigator of the PERSEUS clinical program, at the Cardiovascular Research Foundation's annual Transcatheter Cardiovascular Therapeutics scientific symposium in Washington, D.C.  

"The PERSEUS diabetic subset data showed that the TAXUS Element Stent mitigated the impact of diabetes as a risk factor for restenosis following stenting procedures in the patients studied," said Dr. Cannon.  "At one year, no significant differences in measures of stent efficacy were observed between the two patient groups.  Diabetic status was not a predictor of re-intervention in patients treated with the TAXUS Element Stent."

The PERSEUS diabetic analysis included clinical outcomes at one year among 314 diabetic patients and 852 non-diabetic patients treated with the TAXUS Element Stent from the PERSEUS Workhorse and Small Vessel clinical trials.  Due to significant disparity in baseline characteristics between diabetic and non-diabetic patients, propensity score analysis was used to allow for adjustment of baseline differences (other than the presence of diabetes) between t
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
3. Boston University Biomedical Engineers Find Chink in Bacterias Armor
4. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
5. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
6. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
7. Boston Scientifics Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
8. Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
9. Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results
10. Award-Winning Medicine Wheel Returns to the Cyclorama at the Boston Center for the Arts on Dec. 1 for 24-hour Vigil Recognizing World AIDS Day
11. Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... Va. , Feb. 27, 2015 ... confident or very confident substituting an interchangeable biosimilar ... products share the same nonproprietary name, according to ... Care Pharmacy,s (AMCP,s) Journal of Managed Care ... only about 25 percent of pharmacists would feel ...
(Date:2/27/2015)... , Feb. 27, 2015 The role of ... decade but one thing hasn,t changed: face-to-face meetings are ... relationships with Key Opinion Leaders. Yet at ... most valuable type of interaction, field medical teams within ... KOL interactions. This is just one of the challenges ...
(Date:2/27/2015)... -- Pomerantz LLP is investigating claims on behalf of investors ... VTAE ).  Such investors are advised to ... or 888-476-6529, ext. 237. The investigation ... directors have violated Sections 10(b) and 20(a) of the ... February 27, 2015, the Company announced that its partner ...
Breaking Medicine Technology:Survey Published in AMCP's JMCP Finds Pharmacists Are Most Confident Substituting Interchangeable Biosimilars for Brand Biologics When Products Share Nonproprietary Name 2Improving the Management of MSL Teams to Create Value across a Diverse Set of Customers 2SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vitae Pharmaceuticals, Inc. - VTAE 2
... SETAUKET, N.Y., Dec. 18 Lixte,Biotechnology Holdings, Inc. ... for both detection and treatment of cancer, announced ... Lixte sold 1,000,000,shares of its Common Stock at ... gross,proceeds of $650,000. WestPark Capital, Inc. acted as ...
... MARINO, Calif., Dec. 18 Epeius Biotechnologies,Corporation announced ... in 2007, a truly remarkable year in terms ... a year in,which a definitive meeting entitled "In ... prestigious Cold Spring Harbor Laboratory, where Nobel laureate,James ...
Cached Medicine Technology:Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement 2Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement 3Epeius Biotechnologies Applauds the Belated Scholarship of Their Academic Contemporaries in 2007, As Targeted Gene Therapy Comes of Age in Clinical Medicine 2Epeius Biotechnologies Applauds the Belated Scholarship of Their Academic Contemporaries in 2007, As Targeted Gene Therapy Comes of Age in Clinical Medicine 3
(Date:3/1/2015)... (PRWEB) March 01, 2015 “ The Barrel ... monthly Tech Report, which takes a look at the latest ... Tropeano, the host of NewsWatch and a technology expert, conducted ... spiral adds flavor to drinks. , According to Home Distillation ... the best spirits. Well, there’s a pretty cool product that’ll ...
(Date:2/28/2015)... 2015 The MCA Youth Empowerment Conference ... one platform and gears towards the goal for a ... of group talks in smaller groups will be held ... Personal Development, Leadership, Entrepreneurship, Healthcare, Social and Volunteerism, Women ... Malaysian youths. , Young adults aged between ...
(Date:2/28/2015)... In a recent episode of SCI TV ... Athlete Development Services and Consultancy talks with Joshua ... development and player engagement during and after their careers. ... face and how off-field activities are a critical component ... in athlete development issues while in graduate school coaching ...
(Date:2/28/2015)... The Heart Fit Clinic started doing ... the machine. The Heart Fit Clinic is also selling ... franchise model. The goal is to scale the business ... To buy External Counterpulsation machines can be ... through this process and achieve the desired results. ...
(Date:2/28/2015)... 28, 2015 Mew and Company, a ... they now provide business consulting services in addition to ... tax planning and succession planning. Company finances are a ... professionals. On top of this, complex Canadian tax laws ... accounting. As a result, Mew and Company works to ...
Breaking Medicine News(10 mins):Health News:An Oak Infusion Spiral was Featured on NewsWatch Television on January 30, 2015 2Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 2Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 3Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 4Health News:SCI TV Covers Athlete Development with Duncan Fletcher 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 3Health News:Clinicians Can Now Purchase External Counterpulsation with Heart Fit Clinic 2Health News:Vancouver Corporate Tax Accountants Now Provide Business Consulting Services 2
... According to an inquest heard, a patient was given a lethal ... than 100 hours in a week.// ,Dr Helen Pike, ... her. The patient, Tony Wright, 58 suffered a massive cardiac arrest ... in the hospital’s ICU. ,Once his wife heard about ...
... for a new study has shown that even few pounds overweight ... compared// to those who maintain the optimum weight. ... was conducted involving 500,000 people, which took into consideration their lifestyle ... , ,The study revealed that obese people carried ...
... costs as well as indirect costs for employers, ... Occupational and Environmental// Medicine, official publication of the ... ,Led by Dr. Gene Colice of ... a large insurance database to analyze costs associated ...
... a spurt in cases of diarrhea, nausea, and vomiting, which ... outbreak. ,A common infection at this time ... to have taken a virulent form. It would do good ... infection. It is important to wash hands well after the ...
... has found a way to reduce brain swelling, the most ... doctoral student Renée Turner in the Discipline of Pathology at ... brain seems to mimic a similar process in the skin, ... these are yet to be developed. ,“This potentially ...
... American and South African scientists working at the epicenter ... how the human immunodeficiency virus// (HIV) “exhausts” killer T ... found that HIV can simply “turn off” fully functional ... cells. In test tube studies, however, the scientists showed ...
Cached Medicine News:Health News:Sheer exhaustion makes a junior doc’ kill a patient! 2Health News:Sheer exhaustion makes a junior doc’ kill a patient! 3Health News:Insurance Data Show High Costs of Persistent Asthma 2Health News:How HIV "Exhausts" Killer T Cells 2Health News:How HIV "Exhausts" Killer T Cells 3Health News:How HIV "Exhausts" Killer T Cells 4
... the sulfate ester of DHEA, derived from ... DHEA in adrenal and extradrenal tissues. DHEA ... the adrenal cortex, and is a precursor ... relatively weak androgenic activity, which for unsulfated ...
EL-RF-IgM is high sensitivity quantitative rheumatoid factor IgM....
The Diamedix immunosimplicity® Is- Rheumatoid Factor Test Kit is an EIA procedure intended for the quantitation of IgM antibodies to IgG antigen. The results are reported in IU/mL, traceable to t...
... The SYNCHRON CX4 Delta Specialty / ... access analyzer that can consolidate Drugs ... testing, such as thyroid, HbA1c and ... CX4 Delta offers a level of ...
Medicine Products: